ABL1 and acute lymphoblastic leukemia: We found that ABL/JAK kinase fusion cases were characterized by poor initial response to induction treatment, high MRD levels, and a higher relapse rate compared with non-BCR-ABL1-like B-other ALL cases but a comparable relapse rate as BCR-ABL1-like ALL without tyrosine kinase fusions.